Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A01674 | Pages: 190 | Charts: 50 | Tables: 102 |
The e-prescribing market size was valued at $885.6 million in 2018, and is projected to reach $4,152.7 million by 2026, growing at a CAGR of 21.4% from 2019 to 2026. E-prescribing is an application that sends patients or end users prescriptions electronically from their computer to chosen pharmacies. The primary goal of e-prescribing models in an EHR or HIT systems are efficient transmission and receipt of complete, accurate, and unambiguous prescription orders that help optimize pharmacy processing and fulfillment, thereby eliminating disruptions in workflow and delays in patient care.
Electronic Prescribing (E-prescribing) solutions are widely adopted among healthcare industry due to its benefits such as improved patient safety, fewer medication errors due to handwritten prescriptions, fewer medication errors due to misunderstood phoned-in prescriptions, and less risk of lost or misplaced written prescriptions. This in turn is expected to boost growth of the global e-prescribing market during the forecast period.
The hospital segment registered high revenue growth in 2018 among all the segments in the global electronic prescribing market and is expected to continue this trend over the coming years. This is attributed to rise in adoption of electronic prescribing and medication administration systems with benefits such as accurate communication among healthcare professional and reduced adverse drug events, medication errors, and healthcare costs.
[COMPONENTGRAPH]
North America has garnered high revenue share due to high adoption of e-prescription integrated systems and increase in adoption toward advanced healthcare technology products. This is a major factor to drive the growth of the e-prescribing market forecast. Moreover, as individuals in the region are inclining toward patient-centric solutions, the adoption of e-prescribing is helping physicians in the region to provide exquisite experience without the need to invest in time for visiting the hospital in non-emergence situations. Whereas, the ambulatory care institutes in the region have adopted e-prescribing solutions at a significant rate due to favorable government initiative toward public safety. Aforementioned are factors that support the e-prescribing market growth in the North America region.
[DEPLOYMENTGRAPH]
The report focuses on the growth prospects, restraints, and market analysis. The study provides Porter’s five forces analysis of the e-prescribing industry to understand the impact of various factors such as bargaining power of suppliers, competitive intensity of competitors, threat of new entrants, threat of substitutes, and bargaining power of buyers on the electronic prescribing market.
[APPLICATIONGRAPH]
The e-prescribing market segmentation is based on component, deployment, end user, and region. By component, it is categorized into solutions and services. On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classified into hospitals, office-based physicians, and pharmaceuticals. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
[REGIONGRAPH]
Key players operating in the global e-prescribing market analysis include Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.
The global e-prescribing market is influenced by several factors among which favorable government initiatives and incentive programs have gained high traction and has significantly impacted the growth of the market. Moreover, rise in focus on the reduction of fraud and abuse of controlled substances among healthcare institutions and need to curtail escalating healthcare costs are among some of the major factors to drive growth of the market in the coming years. However, concerns associated with electronic health record (EHR) data security and complex workflow issues associated with integration e-prescribing into existing systems are factors that restrain the market growth to a certain extent. Furthermore, Asia-Pacific countries are expected to garner high adoption rate of e-prescribing owing to on-going healthcare infrastructure development activities, which supports technological advancements in the existing systems,
Initial government initiatives were primarily focused on the integration of technology into healthcare sector to ease patient waiting time and service delivery. Advent of technological transformation in healthcare shifted this focus towards standardizing the fragmented technological advance approaches among which development of standards for e-prescribing systems and implementation gained high momentum from the past decade. Aforementioned is a factor that drive the e-prescribing market trends during the forecast period. For example, in 2011, the U.S. Centers for Medicare & Medicaid Services established the Medicare and Medicaid EHR Incentive Programs, which encouraged eligible hospitals & critical access hospitals, and clinicians to implement, upgrade (AIU), demonstrate, and adopt the advance Certified EHR Technology (CEHRT).
E-prescribing solutions haves been evaluated to have the potential to improve efficiency by streamlining clinical practice workflow throughout the healthcare systems. In addition, these systems have also advanced to improve patient satisfaction with digital care by reducing wait-time at the pharmacy, improved patient compliance, and reduced the cost of medication to patients by automatically recommending cost-effective generics and preferred formulations. Aforementioned features are key indicators that haves supported the growth of the electronic prescribing market and is expected to further garner high revenue growth in the coming years
North America holds the largest share in the e-prescribing market, primarily driven by the United States, where healthcare digitalization and government initiatives like the Health Information Technology for Economic and Clinical Health (HITECH) Act have accelerated the adoption of e-prescribing. The U.S. government has mandated the use of e-prescribing for controlled substances, further driving market growth. Major healthcare systems in the U.S. and Canada are increasingly utilizing e-prescribing to reduce medication errors, improve patient safety, and ensure seamless communication between healthcare providers and pharmacies.
Europe is another significant region in the e-prescribing market, driven by strong regulatory frameworks that promote electronic healthcare solutions. Countries like Germany, France, and the UK are leading in adoption, with governments mandating the implementation of digital healthcare technologies. The European Union’s focus on enhancing patient safety and improving healthcare efficiency through digital transformation is fostering the use of e-prescribing systems. Additionally, the push for interoperable healthcare systems in Europe is supporting the market's expansion, particularly as part of the EU's Digital Single Market strategy.
The Asia-Pacific region is expected to witness the highest growth in the e-prescribing market due to increasing investments in healthcare infrastructure and rising awareness of digital health technologies. Countries like Japan, Australia, and India are key markets. In Japan, the aging population and a well-established healthcare system are driving the need for efficient prescription management. In India, the government's initiatives to digitize healthcare services, including the launch of National Digital Health Mission (NDHM), are accelerating the adoption of e-prescribing platforms, especially in urban areas.
In Latin America, the adoption of e-prescribing is gradually increasing, particularly in countries like Brazil and Mexico. The region's healthcare sector is moving towards digitalization, with governments recognizing the importance of e-prescribing in reducing medication errors and streamlining healthcare processes. However, the market is still in its early stages, and challenges such as the lack of robust healthcare IT infrastructure and limited awareness may slow down growth.
The Middle East & Africa region is slowly adopting e-prescribing technologies, with Saudi Arabia and the UAE being early adopters in the Middle East. The region’s healthcare systems are investing in digital health solutions to improve healthcare outcomes, and e-prescribing is a key component of these initiatives. In Africa, adoption is limited but growing, as countries begin to recognize the potential benefits of e-prescribing in reducing healthcare costs and improving the efficiency of healthcare delivery.
March 2024: Cerner Corporation announced the integration of advanced AI-driven features into its e-prescribing platform to enhance predictive analytics for medication management, aiming to reduce prescription errors in North America.
December 2023: Surescripts, a leading U.S. e-prescribing network, reported a 10% increase in e-prescriptions for controlled substances across the U.S., driven by tighter regulations and greater adoption of digital healthcare practices.
October 2023: DrFirst expanded its partnership with Allscripts in Europe to enhance interoperability between e-prescribing platforms and electronic health record (EHR) systems, facilitating smoother transitions for patients and healthcare providers in Germany and France.
August 2023: Epic Systems launched its cloud-based e-prescribing platform in Australia, focusing on improving patient outcomes by integrating e-prescribing with telehealth services. This move comes as part of the country’s efforts to digitalize healthcare.
June 2023: MediSecure, one of Australia’s largest e-prescribing service providers, announced the rollout of a nationwide initiative in collaboration with the government to ensure wider adoption of e-prescribing in rural areas, addressing healthcare access challenges.
Key Market Segments
Key Market Players
CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs
3.4.2. Restraints
3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues
3.4.3. Opportunities
3.4.3.1. Growth in the developing countries across Asia-Pacific
3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET
CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT
4.1. OVERVIEW
4.2. SOLUTIONS
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. SERVICES
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT
5.1. OVERVIEW
5.2. WEB & CLOUD-BASED
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. ON-PREMISE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: E-PRESCRIBING MARKET, BY END USER
6.1. OVERVIEW
6.2. HOSPITALS
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. OFFICE-BASED PHYSICIANS
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. PHARMACEUTICALS
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: E-PRESCRIBING MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast, by region
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment
7.3.5.1.3. Market size and forecast, by end user
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user
7.3.5.4. Rest of Europe
7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS
8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration
8.4. PATENT ANALYSIS
8.4.1. By region (2016-2019)
8.4.2. By applicant
CHAPTER 9: COMPANY PROFILE
9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ATHENAHEALTH, INC.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. CERNER CORPORATION
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. CHANGE HEALTHCARE
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. DRFIRST
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments
9.6. ECLINICALWORKS
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. EPIC SYSTEMS CORPORATION
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. PRACTICE FUSION, INC.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. SURESCRIPTS
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018–2026 ($MILLION)
TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION 2018–2026 ($MILLION)
TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018–2026 ($MILLION)
TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
TABLE 68. PARTNERSHIP (2016-2019)
TABLE 69. KEY EXPANSION (2016-2019)
TABLE 70. KEY ACQUISITION (2016-2019)
TABLE 71. COLLABORATION (2016-2019)
TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 85. DRFIRST: KEY EXECUTIVES
TABLE 86. DRFIRST: COMPANY SNAPSHOT
TABLE 87. DRFIRST: PRODUCT PORTFOLIO
TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
TABLE 100. SURESCRIPTS: KEY EXECUTIVES
TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018–2026
FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018–2026
FIGURE 04. TOP IMPACTING FACTORS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018–2025
FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018–2026 ($MILLION)
FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
FIGURE 43. PATENT ANALYSIS, BY REGION
FIGURE 44. PATENT ANALYSIS, BY APPLICANT
FIGURE 45. R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016–2018 ($MILLION)
FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. CERNER CORPORATION: REVENUE, 2016–2018 ($MILLION)
FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)